Special NoticePosted Aug 12, 2026·Responses due Aug 18, 2026

6505--JERRY - Radiopharmaceuticals

Veterans Affairs · 241-NETWORK CONTRACT OFFICE 01 (36C241)

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
325412
Value
Not stated
Solicitation
36C24126Q0738
Set-aside
None stated
PSC
6505
Place
Not stated
Contact
Jerry Choinski (jerry.choinski@va.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C24126Q0738 in this department, oldest first.

Early notice
  • Aug 12, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Typical award: Aug 26, 2026 to Oct 30, 2026, middle of the range Sep 14, 2026.
Measured from 403 past early notices at Veterans Affairs, Department of with NAICS 325412 that later posted an award (middle half of cases, counted from Aug 12, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

The Department of Veterans Affairs, Networking Contracting Office (NCO 01) located in West Haven, CT, intends to enter into a sole source procurement with Novartis Pharmaceuticals Corporation for Lu-177 vipivotide tetraxetan (PLUVICTO). Authority: FAR 8.405-6(a)(1)(i) (items peculiar to one manufacturer), FAR 8.405-6(b) (limited-sources justification), MAS ordering authorities at 41 U.S.C. 152(3) and 40 U.S.C. 501, and GSAM/R 538.7104-3(b) as implemented for MAS sole-source justifications (RFO 8.4). STATEMENT OF WORK RADIOPHARMACEUTICALS Lu-177 vipivotide tetraxetan (PLUVICTO) is a radioligand… (show all)

therapeutic agent to perform the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive and metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitor (ARPI) therapy and are considered appropriate to delay taxane-based chemotherapy or have received prior taxane-based chemotherapy. Radiopharmaceutical preparation and delivery of Lu-177 vipivotide tetraxetan (PLUVICTO) doses performed at contractor facility provided by a board-certified radiopharmacist and delivered to the Nuclear Medicine Service at VA Connecticut Healthcare located at 950 Campbell Ave., West Haven, CT, building one, ground floor. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm.� Personnel assigned by the contractor to perform services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. A total of 74 doses of Pluvicto to treat prostate-specific membrane antigen (PSMA)-Positive. Contractor s employees will deliver to the PET/CT Service and give deliveries directly to the PET Technologist on duty. Delivery personnel will be bonded by the contractor. The contractor will provide for the placement of one or more telephone delivery order (s) per day for items listed in the Pricing and Cost Schedule, 24 hours per day, seven days a week, including holidays. Contractor must be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals. The offeror must provide copies of licenses and certifications along with a quote to the Contracting Officer. DELIVERY ORDERS: Due to the demands of the Medical Center care requirements, there shall be no restriction to the number of orders which may be placed by VA, nor the number of deliveries required per day. In the event that the requirements may be determined in advance, a longer delivery time will be scheduled accordingly. The delivery order shall specify contract item (s) and quantity, time (s) of delivery and applicable VA order number. Orders can be placed orally by telephone and/or online. DELIVERY LOCATION: VA Connecticut Healthcare System. 950 Campbell Ave. West Haven, CT 06516. PET Center and/or Mobile PET Unit; building one. Deliveries will be made Monday-Friday (excluding holidays which are listed below) between the hours of 7:00 AM and 3:00 PM. Federal Holidays are as follows and include any other days specifically declared by the President of the United States to be deemed a holiday. New Year s Day Juneteenth Thanksgiving Martin Luther King s Birthday Independence Day Veterans Day Presidents Day Columbus Day Christmas Memorial Day Labor Day Access to the VAMC location during non-business hours shall be obtained by contacting the AOD located in the Emergency Department who will contact VA Police to accompany the delivery Person to the PET Center and supervise the delivery. Deliveries will be supervised by the COR or their designee before beginning delivery operations. The contractor will contact the COR prior to delivery to arrange for delivery supervision. DELIVERY COMMITMENT: Time of delivery specified or mutually agreed to at the time of receipt of telephone order shall become mandatory upon the Contractor. Failure to perform in accordance with the delivery commitment may be grounds for termination of contract in accordance with the provisions for default. PERIOD OF PERFORMANCE: The contract will have a Period of Performance from 9/1/2026 to 8/31/2027. SUPPLIES OR SERVICES AND PRICES/COSTS: Contractor to provide Radiopharmaceutical product, PLUVICTO, as requested by authorized VA Staff, to support the West Haven campus of VA Connecticut Healthcare System (VACHS), 950 Campbell Ave, West Haven, CT 06516. PERSON AUTHORIZED TO PLACE ORDERS: In addition to the Contracting Officer, the COR is authorized to place orders under this contract, as well as any Certified Nuclear Medicine Technologist employed by the West Haven VA Hospital. NOTIFICATION: The services specified herein may be changed by written modification. The modification will be prepared by the VA Contracting Officer. The NAICS code for this requirement is 325412. Novartis Pharmaceuticals Corporation is the only contractor capable of providing PLUVICTO. Novartis Pharmaceuticals Corporation is the sole Food & Drug Administration (FDA) approved source of this highly specialized therapeutic radiopharmaceutical, PLUVICTO (Lutetium Lu-177 Vipivotide Tetraxetan) This notice of intent is not a solicitation nor is it a request for proposal. However, interested parties that believe they can satisfy the requirement must clearly identify their capability to do so in writing by Tuesday, August 18, 2026, at 12 pm EST time. Response should be sent to Jerry Choinski at Jerry.Choinski@va.gov. Information submitted in response to this notice will be used solely to determine whether competitive procedures could be used for this acquisition. A determination not to open this requirement to competition based upon responses to this notice is solely within the discretion of the Government. Disclaimer: A solicitation will not be issued. The Government reserves the right to verify all documentation and is not obligated to award based on responses. A Limited-Sources Justification supporting this sole-source action will be posted after award in accordance with FAR 8.405-6 and FAR 5.301.

Who won similar work

2 award notices on SAM.gov in the last 24 months. Matched by: Same office (241-NETWORK CONTRACT OFFICE 01 (36C241)), same product/service code (PSC) 6505 and NAICS 325412.

WinnerAwardsValueLast
VANTIVE US HEALTHCARE LLC2$667KJun 30, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 1 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.